EpiDisease — Grant · approximately €1.9M

Valencia diagnostics company EpiDisease received about €1.9M of support from CDTI Innovación under the Seal of Excellence programme, funded with MRR / NextGenerationEU money. It is for HistShock, an in-vitro diagnostic kit that flags the risk of deterioration in sepsis patients.